Evidence map›Paper›PMID 9580701›Full record

ArticleNucleic acids research1998

Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles.

Y Z Liu, I K Lee, I Locke, S J Dawson, D S Latchman

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Y Z LiuDepartment of Molecular Pathology, Windeyer Institute of Medical Sciences, University College London Medical School, The Windeyer Building, Cleveland Street, London W1P 6DB, UK.
I K Lee
I Locke
S J Dawson
D S Latchman
University College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

A 40 amino acid region of Oct-2 from amino acids 142 to 181 functions as an active repressor domain capable of inhibiting both basal activity and activation of promoters containing a TATA box, but not of those that contain an initiator element. Based on our observation that the equivalent region of the closely related Oct-1 factor does not act as an inhibitory domain, we have mutated specific residues in the Oct-2 domain in an attempt to probe their importance in repressor domain function. Although mutations of several residues have no or minimal effect, mutation of proline 175 to arginine abolishes the ability to inhibit both basal and activated transcription. In contrast, mutation of proline 174 to arginine confers upon the domain the ability to repress activation of an initiator-containing promoter by acidic activation domains, and also suppresses the effect of the proline 175 mutation. Hence, adjacent proline residues play key roles in the functioning of the inhibitory domain and in limiting its specificity to TATA-box-containing promoters.

Indexed as

Amino Acid SequenceAnimalsCell LineCricetinaeDNA-Binding ProteinsGene Expression RegulationHost Cell Factor C1Molecular Sequence DataMutagenesis, Site-DirectedOctamer Transcription Factor-1ProlineRecombinant Fusion ProteinsRepressor ProteinsTATA BoxTrans-ActivatorsTranscriptional ActivationDNA-Binding ProteinsHost Cell Factor C1Octamer Transcription Factor-1ProlineRecombinant Fusion ProteinsRepressor ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID9580701
PMCPMC147571
OpenAlexW2107981442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.